179 related articles for article (PubMed ID: 29740868)
1. De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy.
Ambrosino P; Soldovieri MV; Bast T; Turnpenny PD; Uhrig S; Biskup S; Döcker M; Fleck T; Mosca I; Manocchio L; Iraci N; Taglialatela M; Lemke JR
Ann Neurol; 2018 Jun; 83(6):1198-1204. PubMed ID: 29740868
[TBL] [Abstract][Full Text] [Related]
2. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.
Jiang X; Raju PK; D'Avanzo N; Lachance M; Pepin J; Dubeau F; Mitchell WG; Bello-Espinosa LE; Pierson TM; Minassian BA; Lacaille JC; Rossignol E
Epilepsia; 2019 Sep; 60(9):1881-1894. PubMed ID: 31468518
[TBL] [Abstract][Full Text] [Related]
3. A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.
Madaan P; Jauhari P; Gupta A; Chakrabarty B; Gulati S
Brain Dev; 2018 Mar; 40(3):229-232. PubMed ID: 29037447
[TBL] [Abstract][Full Text] [Related]
4. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
[TBL] [Abstract][Full Text] [Related]
5. Quinidine therapy for West syndrome with KCNTI mutation: A case report.
Fukuoka M; Kuki I; Kawawaki H; Okazaki S; Kim K; Hattori Y; Tsuji H; Nukui M; Inoue T; Yoshida Y; Uda T; Kimura S; Mogami Y; Suzuki Y; Okamoto N; Saitsu H; Matsumoto N
Brain Dev; 2017 Jan; 39(1):80-83. PubMed ID: 27578169
[TBL] [Abstract][Full Text] [Related]
6. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
[TBL] [Abstract][Full Text] [Related]
8. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
[TBL] [Abstract][Full Text] [Related]
9. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
[TBL] [Abstract][Full Text] [Related]
10. De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy.
Nakashima M; Kato M; Aoto K; Shiina M; Belal H; Mukaida S; Kumada S; Sato A; Zerem A; Lerman-Sagie T; Lev D; Leong HY; Tsurusaki Y; Mizuguchi T; Miyatake S; Miyake N; Ogata K; Saitsu H; Matsumoto N
Ann Neurol; 2018 Apr; 83(4):794-806. PubMed ID: 29534297
[TBL] [Abstract][Full Text] [Related]
11. Mutations in SCN3A cause early infantile epileptic encephalopathy.
Zaman T; Helbig I; Božović IB; DeBrosse SD; Bergqvist AC; Wallis K; Medne L; Maver A; Peterlin B; Helbig KL; Zhang X; Goldberg EM
Ann Neurol; 2018 Apr; 83(4):703-717. PubMed ID: 29466837
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.
Rizzo F; Ambrosino P; Guacci A; Chetta M; Marchese G; Rocco T; Soldovieri MV; Manocchio L; Mosca I; Casara G; Vecchi M; Taglialatela M; Coppola G; Weisz A
Mol Cell Neurosci; 2016 Apr; 72():54-63. PubMed ID: 26784557
[TBL] [Abstract][Full Text] [Related]
13. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias.
Helbig KL; Lauerer RJ; Bahr JC; Souza IA; Myers CT; Uysal B; Schwarz N; Gandini MA; Huang S; Keren B; Mignot C; Afenjar A; Billette de Villemeur T; Héron D; Nava C; Valence S; Buratti J; Fagerberg CR; Soerensen KP; Kibaek M; Kamsteeg EJ; Koolen DA; Gunning B; Schelhaas HJ; Kruer MC; Fox J; Bakhtiari S; Jarrar R; Padilla-Lopez S; Lindstrom K; Jin SC; Zeng X; Bilguvar K; Papavasileiou A; Xing Q; Zhu C; Boysen K; Vairo F; Lanpher BC; Klee EW; Tillema JM; Payne ET; Cousin MA; Kruisselbrink TM; Wick MJ; Baker J; Haan E; Smith N; Sadeghpour A; Davis EE; Katsanis N; ; Corbett MA; MacLennan AH; Gecz J; Biskup S; Goldmann E; Rodan LH; Kichula E; Segal E; Jackson KE; Asamoah A; Dimmock D; McCarrier J; Botto LD; Filloux F; Tvrdik T; Cascino GD; Klingerman S; Neumann C; Wang R; Jacobsen JC; Nolan MA; Snell RG; Lehnert K; Sadleir LG; Anderlid BM; Kvarnung M; Guerrini R; Friez MJ; Lyons MJ; Leonhard J; Kringlen G; Casas K; El Achkar CM; Smith LA; Rotenberg A; Poduri A; Sanchis-Juan A; Carss KJ; Rankin J; Zeman A; Raymond FL; Blyth M; Kerr B; Ruiz K; Urquhart J; Hughes I; Banka S; ; Hedrich UBS; Scheffer IE; Helbig I; Zamponi GW; Lerche H; Mefford HC
Am J Hum Genet; 2018 Nov; 103(5):666-678. PubMed ID: 30343943
[TBL] [Abstract][Full Text] [Related]
14. A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy.
Gururaj S; Palmer EE; Sheehan GD; Kandula T; Macintosh R; Ying K; Morris P; Tao J; Dias KR; Zhu Y; Dinger ME; Cowley MJ; Kirk EP; Roscioli T; Sachdev R; Duffey ME; Bye A; Bhattacharjee A
Cell Rep; 2017 Oct; 21(4):926-933. PubMed ID: 29069600
[TBL] [Abstract][Full Text] [Related]
15. Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45.
Carvill GL; Liu A; Mandelstam S; Schneider A; Lacroix A; Zemel M; McMahon JM; Bello-Espinosa L; Mackay M; Wallace G; Waak M; Zhang J; Yang X; Malone S; Zhang YH; Mefford HC; Scheffer IE
Epilepsia; 2018 Jan; 59(1):e5-e13. PubMed ID: 29171013
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Causative
Gong P; Jiao X; Yu D; Yang Z
Front Genet; 2021; 12():649556. PubMed ID: 34276763
[No Abstract] [Full Text] [Related]
17. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterization of
McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
[TBL] [Abstract][Full Text] [Related]
19. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
Milligan CJ; Li M; Gazina EV; Heron SE; Nair U; Trager C; Reid CA; Venkat A; Younkin DP; Dlugos DJ; Petrovski S; Goldstein DB; Dibbens LM; Scheffer IE; Berkovic SF; Petrou S
Ann Neurol; 2014 Apr; 75(4):581-90. PubMed ID: 24591078
[TBL] [Abstract][Full Text] [Related]
20. KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties.
Cioclu MC; Mosca I; Ambrosino P; Puzo D; Bayat A; Wortmann SB; Koch J; Strehlow V; Shirai K; Matsumoto N; Sanders SJ; Michaud V; Legendre M; Riva A; Striano P; Muhle H; Pendziwiat M; Lesca G; Mangano GD; Nardello R; ; Lemke JR; Møller RS; Soldovieri MV; Rubboli G; Taglialatela M
Ann Neurol; 2023 Aug; 94(2):332-349. PubMed ID: 37062836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
